生殖史不影响体外受精后首次冻融胚胎移植的活产率和围产结局:对25 329个未行胚胎植入前非整倍体遗传学检测周期的分析
本研究为回顾性队列研究,纳入2014年1月至2020年12月间在大学附属生殖中心接受首次冻融胚胎移植且未行胚胎植入前非整倍体遗传学检测的25 329名女性,按生殖史分为无既往妊娠、既往终止妊娠、既往妊娠丢失、既往异位妊娠和既往活产五组。多因素回归和倾向性评分匹配显示,与无既往妊娠者相比,有既往终止妊娠、妊娠丢失、异位妊娠或活产史的女性活产率和围产结局未受损,但既往终止妊娠或异位妊娠者胚胎移植后异位妊娠风险升高。
要点
- 既往终止妊娠、妊娠丢失、异位妊娠或活产史不降低首次冻融胚胎移植后的活产率。
- 既往终止妊娠或异位妊娠者胚胎移植后异位妊娠风险升高。
- 生殖史与不良围产结局风险增加无关。
核心结论
- 与无既往妊娠的女性相比,有既往终止妊娠、妊娠丢失、异位妊娠或活产史的女性在未行胚胎植入前非整倍体遗传学检测的冻融胚胎移植后活产率和围产结局未受损,但既往终止妊娠或异位妊娠者异位妊娠风险升高。
研究设计与样本
- 回顾性队列研究,纳入2014年1月至2020年12月间在大学附属生殖中心接受首次冻融胚胎移植且未行胚胎植入前非整倍体遗传学检测的女性,最终分析25 329名。
- 按生殖史分为无既往妊娠(参照组)、既往终止妊娠、既往妊娠丢失、既往异位妊娠和既往活产五组。
- 采用多因素logistic回归控制年龄、体重指数、教育水平、不孕 duration 和原因、授精方式、内膜准备类型、移植胚胎数、胚胎发育阶段、移植胚胎质量、治疗年份和内膜厚度等混杂因素,并用倾向性评分匹配验证主要发现的稳健性。
主要发现
- 单因素分析中,除既往异位妊娠外,各生殖史类型均与体外受精后较差的妊娠结局显著相关,包括阳性妊娠试验率、临床妊娠率、妊娠丢失率和活产率,与无既往妊娠组比较。
- 多因素回归校正后,研究组与对照组间活产率、妊娠丢失率、阳性妊娠试验率和临床妊娠率的差异不再显著。
- 既往终止妊娠或异位妊娠者胚胎移植后异位妊娠风险升高。
- 与对照组相比,生殖史与不良围产结局风险增加无关。
- 倾向性评分匹配模型获得相似结果,证实主要发现的稳健性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the effect of women's reproductive history on live-birth rate and perinatal outcome after first frozen-thawed embryo transfer (FET) without preimplantation genetic testing for aneuploidy. METHODS: This was a retrospective cohort study of women who had undergone their first FET cycle between January 2014 and December 2020 at a university-affiliated fertility center. No transferred embryo underwent preimplantation genetic testing for aneuploidy. The women were categorized into five groups based on their reproductive history: no previous pregnancy; previous termination of pregnancy (TOP); previous pregnancy loss; previous ectopic pregnancy (EP); and previous live birth. The women with no previous pregnancy were considered as the reference group. The primary outcome was the live-birth rate and secondary endpoints included rates of positive pregnancy test, clinical pregnancy, pregnancy loss and EP as well as perinatal outcomes such as birth weight and preterm birth. Multivariable logistic regression analyses were used to control for a number of potential confounders, including age, body mass index, education level, duration and cause of infertility, insemination method, type of endometrial preparation, number of embryos transferred, embryo developmental stage, quality of the embryos transferred, year of treatment and endometrial thickness. Additionally, propensity score matching (PSM) was used to check the robustness of the main findings. RESULTS: In total, 25 329 women were included in the final analysis. On univariate analysis, each reproductive-history type except for previous EP was significantly associated with worse pregnancy outcome following in-vitro fertilization (IVF), including rates of positive pregnancy test, clinical pregnancy, pregnancy loss and live birth, when compared with the group of women with no previous pregnancy. However, after correcting for several potential confounders, the differences in rates of live birth, pregnancy loss, positive pregnancy test and clinical pregnancy were no longer significant between the study and control groups on multivariable regression models, while the risk of EP after embryo transfer was elevated among women with a previous TOP or EP. There was no increased risk of adverse perinatal outcome associated with reproductive history compared with the control group. Notably, similar results were obtained from the PSM models, confirming the robustness of the main findings. CONCLUSION: Relative to women without a previous pregnancy, those with a prior TOP, pregnancy loss, EP or live birth did not have compromised live-birth rate or perinatal outcomes following FET without preimplantation genetic testing for aneuploidy, with the exception of an increased risk of EP in those with prior TOP or EP. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Chen D, Xu Q, Mao X, et al. Reproductive history does not compromise subsequent live birth and perinatal outcome following in-vitro fertilization: analysis of 25 329 first frozen-thawed embryo transfer cycles without preimplantation genetic testing for aneuploidy. Ultrasound Obstet Gynecol. 2023. PMID: 37058394. doi:10.1002/uog.26220
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。